CagriSema combines semaglutide, the active ingredient in Wegovy, with a molecule that mimics a pancreatic hormone.

Recently, there has been a lot of buzz around GLP-1 weight loss injections. Talk of Ozempic or Wegovy has been hard to miss.

Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

SALT LAKE CITY - LifeVantage Corporation (NASDAQ:LFVN), a $271 million market cap player in the health and wellness sector with impressive 79% gross profit margins, today announced the successful ...

LifeVantage (LFVN) announced the completion of an international in vitro cell study that investigated the effects of its international ...

American host and television producer Oprah Winfrey recently shared her initial experience of taking the weight loss drug GLP ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

An hour of moderate-intensity exercise reduced sensations of hunger in people with overweight and obesity in a recent study.

A gut microbe has been identified that mimics the effects of Ozempic to mitigate diabetes and obesity. Here's how to take ...

GLP-1 drugs mimic a hormone that sends the brain signals of fullness. Researchers theorize that the drugs could work the same ...

As “GLP-1 receptor agonists,” they mimic a naturally occurring hormone, GLP-1, released in the body after someone eats. For reasons that remain unclear, many patients that struggle with ...